Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway

Brain Tumor Pathology

Volumn 31, Issue 4, 2014, Pages 234-241

  Han, Zheng Xiang ^a   Wang, Xiao Xia ^a   Zhang, Shang Nuan ^a   Wu, Jin Xia ^a   Qian, He ya ^a   Wen, Yi yang ^a   Tian, Hui ^a   Pei, Dong Sheng ^a   Zheng, Jun Nian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Egr1 (early growth response protein 1); Glioma; Invasion; Migration; MMP2 (matrix metalloproteinase 2); PAK5

Indexed keywords

CASPASE 3; CASPASE 8; CYCLIN D1; EARLY GROWTH RESPONSE FACTOR 1; GELATIN; GELATINASE A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; P21 ACTIVATED KINASE; P21 ACTIVATED KINASE 5; PROCASPASE 3; PROTEIN P21; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; EGR1 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; PAK7 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ASSAY; CELL GROWTH ASSAY; CELL INVASION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO SCRATCH ASSAY; MIGRATION INHIBITION; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; U251 CELL LINE; U87 CELL LINE; WESTERN BLOTTING; ZYMOGRAPHY; BRAIN TUMOR; CELL CYCLE; CELL MOTION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; TUMOR INVASION;

APOPTOSIS; BRAIN NEOPLASMS; CELL CYCLE; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; P21-ACTIVATED KINASES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84919469203     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-013-0161-1     Document Type: Article

References (32)

1. Frappaz D, Chinot O, Bataillard A, Ben Hassel M, Capelle L et al (2003) Summary version of the standards, options and recommendations for the management of adult patients with intracranial glioma (2002). Br J Cancer 89(Suppl 1):S73–S83
2. Parney IF, Chang SM (2003) Current chemotherapy for glioblastoma. Cancer J 9:149–156
3. Laperriere N, Zuraw L, Cairncross G (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64:259–273
4. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466
5. Somanath PR, Vijai J, Kichina JV, Byzova T, Kandel ES (2009) The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene 28:2365–2369
6. Marlin JW, Eaton A, Montano GT, Chang YW, Jakobi R (2009) Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death. Neoplasia 11:286–297
7. Maroto B, Ye MB, von Lohneysen K, Schnelzer A, Knaus UG (2008) P21-activated kinase is required for mitotic progression and regulates Plk1. Oncogene 27:4900–4908
8. Pandey A, Dan I, Kristiansen TZ, Watanabe NM, Voldby J et al (2002) Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 21:3939–3948
9. Dan C, Nath N, Liberto M, Minden A (2002) PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol Cell Biol 22:567–577
10. Li X, Minden A (2003) Targeted disruption of the gene for the PAK5 kinase in mice. Mol Cell Biol 23:7134–7142
11. Gong W, An Z, Wang Y, Pan X, Fang W et al (2009) P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration. Int J Cancer 125:548–555
12. Cotteret S, Jaffer ZM, Beeser A, Chernoff J (2003) p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol Cell Biol 23:5526–5539
13. Wu X, Frost JA (2006) Multiple Rho proteins regulate the subcellular targeting of PAK5. Biochem Biophys Res Commun 351:328–335
14. Mei PJ, Bai J, Liu H, Li C, Wu YP et al (2011) RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration. J Cancer Res Clin Oncol 137:1823–1830
15. Nigg EA (1995) Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. BioEssays 17:471–480
16. Thiel G, Cibelli G (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287–292
17. Zcharia E, Atzmon R, Nagler A, Shimoni A, Peretz T et al (2012) Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor. Anticancer Drugs 23:1022–1031
18. Tsang CM, Yip YL, Lo KW, Deng W, To KF et al (2012) Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci USA 109:E3473–E3482
19. Ferraz C, Lorenz S, Wojtas B, Bornstein SR, Paschke R et al (2013) Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis. J Clin Endocrinol Metab 98:E8–E16
20. Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z (2012) Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer Invest 30:630–636
21. Vizkeleti L, Ecsedi S, Rakosy Z, Orosz A, Lazar V et al (2012) The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Tumour Biol 33:2189–2199
22. Wang X, Gong W, Qing H, Geng Y, Zhang Y et al (2010) p21-Activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells. Tumour Biol 31:575–582
23. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277:13430–13437
24. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES (1996) Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 93:14486–14491
25. Rosenberg GA (1995) Matrix metalloproteinases in brain injury. J Neurotrauma 12:833–842
26. Ray JM, Stetler-Stevenson WG (1994) The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062–2072
27. Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289–303
28. Woessner JF Jr, Gunja-Smith Z (1991) Role of metalloproteinases in human osteoarthritis. J Rheumatol Suppl 27:99–101
29. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260–1270
30. Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T et al (2004) Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 21:105–112
31. Wang M, Wang T, Liu S, Yoshida D, Teramoto A (2003) The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 20:65–72
32. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T et al (1994) Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12:296–304